TABLE 4.
Drug | Molecule | Target | Disease | Reference |
---|---|---|---|---|
mRNA-1273 | mRNA | Spike (S) protein of SARS-CoV-2 | COVID-19 | USFDA, (2021a) |
BNT162b1 | RBD of Spike glycoprotein | USFDA, (2021b) | ||
Patisiran | siRNA | Polyneuropathy | Hereditary transthyretin-mediated amyloidosis | Adams et al. (2018) |
Givosiran | siRNA | ALAS1 | AHP | USFDA, (2019) |
Pegaptanib | Aptamer | VEGF | AMD | Vinores, (2006) |